1. Background Levels of Neomorphic 2-hydroxyglutarate Facilitate Proliferation of Primary Fibroblasts
   A. DVOŘÁK et al, 2017, Physiological Research CrossRef
2. Metabolic Reprogramming and the Recovery of Physiological Functionality in 3D Cultures in Micro-Bioreactors
   Krzysztof Wrzesinski et al, 2018, Bioengineering CrossRef
3. Emerging roles of ATRX in cancer
   L Ashley Watson et al, 2015, Epigenomics CrossRef
4. Biological Significance of Mutant Isocitrate Dehydrogenase 1 and 2 in Gliomagenesis
   Shigeo OHBA et al, 2016, Neurologia medico-chirurgica CrossRef
5. The role of IDH mutations in acute myeloid leukemia
   Guillermo Montalban-Bravo et al, 2018, Future Oncology CrossRef
6. R132H mutation in IDH1 gene reduces proliferation, cell survival and invasion of human glioma by downregulating Wnt/β-catenin signaling
   Daming Cui et al, 2016, The International Journal of Biochemistry & Cell Biology CrossRef
7. Genomics Analysis of Metabolic Pathways of Human Stem Cell-Derived Microglia-Like Cells and the Integrated Cortical Spheroids
   Julie Bejoy et al, 2019, Stem Cells International CrossRef
8. Role of AHR and HIF-1α in Glioblastoma Metabolism
   Galina Gabriely et al, 2017, Trends in Endocrinology & Metabolism CrossRef
9. Heterozygous IDH1R132H/WT created by “single base editing” inhibits human astroglial cell growth by downregulating YAP
   Shuang Wei et al, 2018, Oncogene CrossRef
10. The R132H mutation in IDH1 promotes the recruitment of NK cells through CX3CL1/CX3CR1 chemotaxis and is correlated with a better prognosis in gliomas
    Feifei Ren et al, 2019, Immunology & Cell Biology CrossRef
11. Extracellular vesicles shed by glioma cells: pathogenic role and clinical value
    Dimitry A. Chistiakov et al, 2014, Tumor Biology CrossRef
12. The Impact of Hypoxia and Mesenchymal Transition on Glioblastoma Pathogenesis and Cancer Stem Cells Regulation
    Michael Karsy et al, 2016, World Neurosurgery CrossRef
13. The driver and passenger effects of isocitrate dehydrogenase 1 and 2 mutations in oncogenesis and survival prolongation
    Remco J. Molenaar et al, 2014, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
14. Molecular mechanisms involved in gliomagenesis
    Toru Kondo, 2017, Brain Tumor Pathology CrossRef
15. Monoamine oxidase B levels are highly expressed in human gliomas and are correlated with the expression of HiF-1α and with transcription factors Sp1 and Sp3
    Martyn A. Sharpe et al, 2016, Oncotarget CrossRef
16. IDH2 mutation in gliomas including novel mutation
    Jaemoon Koh et al, 2015, Neuropathology CrossRef
17. To be Wild or Mutant: Role of Isocitrate Dehydrogenase 1 (IDH1) and 2-Hydroxy Glutarate (2-HG) in Gliomagenesis and Treatment Outcome in Glioma
    Bharathan Bhavya et al, 2020, Cellular and Molecular Neurobiology CrossRef
18. High expression of PIM2 induces HSC proliferation in myelodysplastic syndromes via the IDH1/HIF1‑α signaling pathway
    Zhaoyun Liu et al, 2019, Oncology Letters CrossRef
19. Current biomarker-associated procedures of cancer modeling-a reference in the context of IDH1 mutant glioma
    Narges Zare Mehrjardi et al, 2020, Cell Death & Disease CrossRef
20. Metabolic Remodeling in Glioma Immune Microenvironment: Intercellular Interactions Distinct From Peripheral Tumors
    Runze Qiu et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
21. Effects of microRNA-26b on proliferation and invasion of glioma cells and related mechanisms
    Yun-Ping Li et al, 2017, Molecular Medicine Reports CrossRef
22. Emodin attenuates severe acute pancreatitis-associated acute lung injury by suppressing pancreatic exosome-mediated alveolar macrophage activation
    Qian Hu et al, 2022, Acta Pharmaceutica Sinica B CrossRef
23. Identification of a Prognostic Hypoxia-Associated Gene Set in IDH-Mutant Glioma
    Philip Dao Trong et al, 2018, International Journal of Molecular Sciences CrossRef
24. Control of the Antitumor Immune Response by Cancer Metabolism
    Charlotte Domblides et al, 2019, Cells CrossRef